Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Anand, E. Gray, T. Brown, J. Clewley, B. Cohen (1987)
Human parvovirus infection in pregnancy and hydrops fetalis.The New England journal of medicine, 316 4
M Morfini, G Longo, FP Rossi (1992)
Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus.Am J Hematol, 39
Larry Anderson (1987)
Role of parvovirus B19 in human disease.The Pediatric infectious disease journal, 6 8
A. Zanella, F. Rossi, C. Cesana, A. Foresti, F. Nador, A. Binda, G. Lunghi, M. Cappellini, M. Furione, G. Sirchia (1995)
Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 35
L. Leventhal, S. Naides, B. Freundlich (1991)
Fibromyalgia and parvovirus infection.Arthritis and rheumatism, 34 10
W. Koch, G. Massey, Clifton Russell, S. Adler (1990)
Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.The Journal of pediatrics, 116 3
H. Faden, G. Gary, Larry Anderson (1992)
Chronic parvovirus infection in a presumably immunologically healthy woman.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 15 4
M. Piet, S. Chin, A. Prince, B. Brotman, A. Cundell, B. Horowitz (1990)
The use of tri(n‐butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionationTransfusion, 30
H. Rollag, B. Solheim, J. Svennevig (1998)
Viral Safety of Blood Derivatives by Immune NeutralizationVox Sanguinis, 74
A. Azzi, S. Ciappi, K. Zakvrzewska, M. Morfini, G. Mariani, P. Mannucci (1992)
Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentratesAmerican Journal of Hematology, 39
LC Corman, DJ Dolson (1992)
Polyarteritis nodosa and parvovirus B19 infection (letter).Lancet, 339
D. Denning, A. Amos, P. Rudge, B. Cohen (1987)
Neuralgic amyotrophy due to parvovirus infection.Journal of Neurology, Neurosurgery & Psychiatry, 50
H. Hart, W. Hart, J. Crossley, A. Perrie, D. Wood, A. John, F. Mcomish (1994)
Effect of Terminal (Dry) Heat Treatment on Non‐Enveloped Viruses in Coagulation Factor ConcentratesVox Sanguinis, 67
A. Grosse-Bley, A. Eis-Hübinger, R. Kaiser, J. Oldenburg, H. Brackmann, T. Schwarz, K. Schneweis (1994)
Serological and Virological Markers of Human Parvovirus B19 Infection in Sera of HemophiliacsThrombosis and Haemostasis, 72
A. Eis-Hübinger, U. Sasowski, H. Brackmann (1999)
Parvovirus B19 DNA Contamination in Coagulation Factor VIII ProductsThrombosis and Haemostasis, 81
D. Lyon, C. Chapman, Carol Martin, K. Brown, J. Clewley, A. Flower, V. Mitchell (1989)
SYMPTOMATIC PARVOVIRUS B19 INFECTION AND HEAT-TREATED FACTOR IX CONCENTRATEThe Lancet, 333
K. Peerlinck, P. Goubau, R. Reybrouck, J. Desmyter, J. Vermylen (1995)
Parvovirus B19 Antibodies in Patients with Haemophilia AThrombosis and Haemostasis, 73
M. Williams, B. Cohen, A. Beddall, K. Pasi, P. Mortimer, F. Hill (1990)
Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 58
K. Zakrzewska, A. Azzi, G. Patou, Massimo Morfini, D. Rafanelli, J. Pattison (1992)
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reactionBritish Journal of Haematology, 81
N. Luban (1994)
Human parvoviruses: implications for transfusion medicineTransfusion, 34
F. Mcomish, P. Yap, A. Jordan, H. Hart, B. Cohen, P. Simmonds (1993)
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionJournal of Clinical Microbiology, 31
(1990)
Prospective study of human parvovirus (B19) infection in pregnancy.BMJ, 300
H. Matsui, M. Sugimoto, S. Tsuji, M. Shima, J. Giddings, A. Yoshioka (1999)
Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.Journal of pediatric hematology/oncology, 21 1
L. Corman, D. Dolson (1992)
Polyarteritis nodosa and parvovirus B19 infectionThe Lancet, 339
M. Anderson, P. Higgins, L. Davis, J. Willman, S. Jones, I. Kidd, J. Pattison, D. Tyrrell (1985)
Experimental parvoviral infection in humans.The Journal of infectious diseases, 152 2
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
A. Eis-Hübinger, U. Sasowski, H. Brackmann, R. Kaiser, B. Matz, K. Schneweis (1996)
Parvovirus B19 DNA Is Frequently Present in Recombinant Coagulation Factor VIII ProductsThrombosis and Haemostasis, 76
J. Saldanha, P. Minor (1996)
Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufactureBritish Journal of Haematology, 93
A. Azzi, A. Azzi, Massirno Morfini, Massirno Morfini, P. Mannucci, P. Mannucci (1999)
The transfusion-associated transmission of parvovirus B19.Transfusion medicine reviews, 13 3
Y. Yoto, T. Kudoh, K. Haseyama, N. Suzuki, Takanori Oda, T. Katoh, Tsuneo Takahashi, Sadami Sekiguchi, Shunzo Chiba (1995)
Incidence of human parvovirus B19 DNA detection in blood donorsBritish Journal of Haematology, 91
T. Yee, Christine Lee, K. Pasi (1995)
Life-threatening human parvovirus B19 infection in immunocompetent haemophiliaThe Lancet, 345
C. Prowse, C. Ludlam, P. Yap (1997)
Human Parvovirus B19 and Blood ProductsVox Sanguinis, 72
Glen Mandahl, G. Gulbransen, E. Cardis, Dr Darby, I. Kawachi, R. Winkelmann, J. Auld (1990)
Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.British Medical Journal, 300
O. Corsi, A. Azzi, M. Morfini, R. Fanci, P. Ferrini (1988)
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 25
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
K. Koerner, M. Cardoso, T. Dengler, M. Kerowgan, Bernhard Kubanek (1998)
Estimated Risk of Transmission of Hepatitis C Virus by Blood TransfusionVox Sanguinis, 74
M. Morfini, G. Longo, P. Ferrini, A. Azzi, C. Zakrewska, S. Ciappi, P. Kolumban (1992)
Letter to the editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirusAmerican Journal of Hematology, 39
Larry Anderson, C. Tsou, Robert Parker, Terence Chorba, H. Wulff, P. Tattersall, P. Mortimer (1986)
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assayJournal of Clinical Microbiology, 24
G. Yee, D. Stanley, L. Pessa, T. Costa, S. Beltz, J. Ruiz, D. Lowenthal (1995)
Effect of grapefruit juice on blood cyclosporin concentrationThe Lancet, 345
J. Lefrère, M. Mariotti, M. Thauvin (1994)
B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentratesThe Lancet, 343
J. Jordan, B. Tiangco, J. Kiss, W. Koch (1998)
Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 75
D. Erdman, B. Anderson, T. Török, T. Finkel, L. Anderson (1997)
Possible transmission of parvovirus B19 from intravenous immune globulinJournal of Medical Virology, 53
BJ Cohen, S. Beard, WA Knowles, J. Ellis, D. Joske, J. Goldman, P. Hewitt, K. Ward (1997)
Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusionTransfusion, 37
J. Lefrère, M. Mariotti, I. Croix, J. Lerable, M. Thauvin, T. Burnouf, G. Folléa (1995)
Albumin batches and B19 parvovirus DNATransfusion, 35
A. Woolf, G. Campion, Alice Chishick, S. Wise, B. Cohen, P. Klouda, Owen Caul, P. Dieppe (1989)
Clinical manifestations of human parvovirus B19 in adults.Archives of internal medicine, 149 5
Copland Jg, Davies Ct (1964)
TELEVISION AND TEACHING.The Lancet, 1
E. Santagostino, P. Mannucci, A. Gringeri, A. Azzi, M. Morfini, R. Musso, R. Santoro, M. Schiavoni (1997)
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilizationTransfusion, 37
BACKGROUND: Lipid‐enveloped viruses such as HIV, HBV, and HCV can be inactivated by treatment with solvents and detergents. HAV and human parvovirus B19 lack lipid envelopes and are not inactivated. Solvent/detergent‐treated pooled plasma (S/D plasma) contains neutralizing antibodies, but it is not known whether the parvovirus B19 antibody content is sufficient to prevent transmission of the disease. A patient is described who developed a clinical illness due to parvovirus B19 infection after the infusion of S/D plasma.
Transfusion – Wiley
Published: Jan 1, 2000
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.